ArticlePharmacology research & perspectives2016

Efficacy and safety evaluation of claudin-4-targeted antitumor therapy using a human and mouse cross-reactive monoclonal antibody.

Yosuke Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.